The Priority Review

Tag

JPY

1 story

  1. Regulation

    Sales of Leqembi total 32.2 billion yen in third quarter 2026

    BioArctic AB reported preliminary global revenue for Leqembi of JPY 32.2 billion in the third quarter 2026, generating a royalty of SEK 203.8 million, up about 74 percent from the same period in 2025. The company disclosed the figures under the EU Market Abuse Regulation on October 28 2026.